-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IE9+hQHBxT5xDXpU+vopRiSr6TknZ13y9JbOJH+wFr+at7pvREr7J4IpiRCHpmtk u+be4u5fvSf99e1BsRyUXg== 0000950135-08-000569.txt : 20080206 0000950135-08-000569.hdr.sgml : 20080206 20080206170033 ACCESSION NUMBER: 0000950135-08-000569 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080206 DATE AS OF CHANGE: 20080206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Archemix Corp. CENTRAL INDEX KEY: 0001143527 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043511153 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-144837 FILM NUMBER: 08582033 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7700 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ARCHEMIX CORP DATE OF NAME CHANGE: 20010621 RW 1 b65464rwrw.htm ARCHEMIX CORP., REQUEST FOR WITHDRAWAL rw
 

ARCHEMIX CORP.
300 Third Street
Cambridge, MA 02142
February 6, 2008                    
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Filing Desk
     
Re:
  Archemix Corp.
Request for Withdrawal of Registration Statement on Form S-1 (File No. 333-144837) and
Registration Statement on Form 8-A (File No. 001-33786)
Ladies and Gentlemen:
     On July 25, 2007, Archemix Corp., a Delaware corporation (the “Company”), filed a Registration Statement on Form S-1 (File No. 333-144837) (together with the exhibits and amendments thereto, the “Registration Statement”) under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”).
     Pursuant to Rule 477 under the Securities Act, the Company hereby requests that the Commission consent to the withdrawal of the Registration Statement effective as of the date hereof or at the earliest practicable date hereafter. The Company is requesting such withdrawal because of unfavorable market conditions that would adversely affect the offering of the securities under the Registration Statement. The Registration Statement has not been declared effective by the Commission and no securities have been issued or sold under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a).
     The Company also advises the Commission pursuant to Rule 477(c) that it may undertake a subsequent private offering in reliance on Rule 155(c) under the Securities Act.
     The Company acknowledges that no refund will be made for fees paid to the Commission in connection with filing of the Registration Statement. However, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use should the Company proceed with the filing of a subsequent registration statement meeting the requirements of Rule 457(p) under the Securities Act.
     Additionally, the Company requests that the Commission consent to the withdrawal of the Company’s Registration Statement on Form 8-A (File No. 001-33786), filed on October 31, 2007 under the Securities Exchange Act of 1934, as amended, with the Commission, with such request to be approved effective as of the date hereof or at the earliest practicable date hereafter.

 


 

     Please address any questions you may have to Megan N. Gates, Esq. and Scott A Samuels, Esq. at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, Massachusetts 02111, telephone numbers (617) 348-4443 and (617) 348-1798, facsimile number (617) 542-2241.
     Thank you for your assistance with this matter.
         
  ARCHEMIX CORP.
 
 
  By:   /s/ Errol B. De Souza    
    Errol B. De Souza   
    President and Chief Executive Officer   
 
     
cc:
  Securities and Exchange Commission
Division of Corporation Finance
  Jeffrey P. Riedler, Assistant Director
  John L. Krug, Esq.
  Gustavo Rodriguez
 
   
 
  Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  Jeffrey M. Wiesen, Esq.
  Megan N. Gates, Esq.
  Scott A Samuels, Esq.
 
   
 
  Wilmer Cutler Pickering Hale and Dorr LLP
  David E. Redlick, Esq.
  Stuart R. Nayman, Esq.

 

-----END PRIVACY-ENHANCED MESSAGE-----